You are here

Home > Personalized medicine

Personalized medicine

Weizmann Institute of Science and Clalit Health Services Will Collaborate to Advance the Field of Personalized Medicine and Improve Health Care Services
Weizmann Institute of Science and Clalit Health Services Will Collaborate to Advance the Field of Personalized Medicine and Improve Health Care Services
10.03.2014
Theoretical Physics, Disease, Drugs & Diagnostics

Weizmann Institute scientists, Clalit Health Services physicians and legal advisor, and information system experts from both organizations...

The Weizmann Institute of Science Receives 120 Million Dollars to Establish the Nancy and Stephen Grand Israel National Center for Personalized Medicine
The Weizmann Institute of Science Receives 120 Million Dollars to Establish the Nancy and Stephen Grand Israel National Center for Personalized Medicine
11.11.2013
Personalized Medicine, Disease, Drugs & Diagnostics
The Weizmann Institute of Science is establishing, on its campus, the Nancy and Stephen Grand Israel National Center for...
Pre-leukemic stem cells (top) with both mutated and healthy copies of the RUNX1 gene already display some of the characteristics of acute myeloid leukemia (AML). When the non-mutated copy of the gene is inactivated, disruptions in the spindle-assembly-checkpoint phase of cell division trigger cell death
Leukemia Cells are Addicted to a Healthy Gene
29.09.2013
Cancer, Personalized Medicine, Molecular and Cell Biology, Genetics

Weizmann Institute researchers discover that a “standoff” between a mutated gene and its normal counterpart keeps certain cancer cells alive...

New Developments
New Developments
19.05.2013

 

 
Non-invasive image from the bioimaging center showing blood (red) and lymphatic (green) vessels that were induced to grow by, and in tum facilitate progression of a growing tumor (blue).The ability of tumors to induce local expansion of blood and lymphatic vessels is a critical step in tumor progression and metastatic spread. Targeting these vessels provides an important strategy for novel anti-cancer treatment. Image courtesy Prof. Michal Neeman
2012 and Beyond
16.05.2013
New initiatives and construction at the Weizmann Institute
“Deregulation scores” of hundreds of brain tumor patients: Each row corresponds to a pathway (that is, a biochemical process), and each column to a sample taken from a patient. Every colored spot stands for a number – the value of the “deregulation score” of the corresponding pathway, as determined for a particular patient. Dark blue stands for the activity of the pathway in normal brain tissue, whereas dark red indicates a high level of deviation from normal behavior. The clearly distinct group of normal b
The Path to Personalized Prognosis
13.05.2013
Cancer, Personalized Medicine, Molecular and Cell Biology, Genetics, Bioinformatics and Computational Biology

A new approach to personalized cancer therapy profiles a tumor by its biological pathways

Drs. Yotam Drier (left) and Gad Getz at the Broad Institute
Cancer at a Breaking Point
16.12.2012
Bioinformatics and Computational Biology

A unique collaboration is helping map out the genetics of cancer

Dr. Ido Amit
The Gene Control Hierarchy
29.11.2012
Personalized Medicine, Molecular and Cell Biology, Immunology, Genetics

A new, automated method for mapping protein-DNA interactions may lead to advances in personalized medicine

Regulatory factor hierarchy: The highest level (top) determines a cell’s basic identity; the second (middle) shapes its properties; the third (bottom) activates genes according to changing conditions
Uncovering the Genome’s Regulatory Code
09.09.2012
Personalized Medicine, Molecular and Cell Biology, Immunology, Genetics

A new, automated method for mapping protein-DNA interactions may lead to advances in personalized medicine
 

Pages

Top Stories

See All >
Shutterstock

Shedding Light on the Dark Hours

Credit: Coleen Murphy, Princeton University, Princeton, NJ

Cracking the Code of a Worm's Throat

“Eight Shining Examples of Excellence”

Shutterstock

Burning Cancer’s Bridges

Press Releases
See All >
11.11.2024
“Eight Shining Examples of Excellence”
27.08.2024
The Weizmann Institute of Science Ranked among the World’s Top Ten Academic Institutions
Shutterstock
26.08.2024
A Discovery to Set Your Heart a-Knocking
Most Popular Articles

The Limits of Computing

Computers can solve complex problems but they are far from omnipotent. Prof. Ran Raz of the Weizmann Institute's Computer Science and Applied Mathematics Department is trying to portray the limits...

Prof. Zvi Artstein, Vice President for Technology Transfer

Prof. Zvi Artstein

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.